You searched for "impaired"
Impact of preop occlusion on surgical outcome
The purpose of this study was to evaluate the effect of improved control with part-time occlusion treatment on the final postoperative surgical outcome in patients with intermittent exotropia. Eighty-nine patients were recruited who had unilateral lateral rectus recess / reset...
How does teprotumumab impact on ocular misalignment in thyroid eye disease?
A retrospective case review was conducted with the aim of exploring the effect of teprotumumab on objective diplopia. Adults diagnosed with thyroid eye disease, presenting with diplopia and receiving a standard six-month treatment with teprotumumab at a single centre were...The ophthalmologist’s elbow: a potentially painful point of contact
Three months ago I leant, in the customary manner, on the box of my indirect lens at the slit lamp to examine a patient’s fundus. An acute and severe pain in the tip of my elbow immediately interrupted me. I...Tips for the Online Proctored FRCOphth - Part 1
The FRCOphth Part 1 examination is a difficult exam in itself, testing candidates on a wide range of theoretical and biomedical ophthalmology. This used to be a two-part pencil-on-paper written examination, which was then digitalised for October 2019 and January...Minimally Invasive Glaucoma Surgery: What options are there and when might they be considered?
In recent years there has been a rapid expansion in a group of operations termed ‘minimally invasive’ or ‘micro invasive’ glaucoma surgery (MIGS). These options generally offer less significant IOP reduction, but with a more favourable safety profile when compared...
High dose (2.5mg) bevacizumab for postradiation cystoid macular oedema
The authors present a retrospective, interventional case series investigating the efficacy of high dose (2.5mg/0.1ml) intravitreal bevacizumab in the treatment of persistent postradiation (Iodine-125 plaque brachytherapy for uveal melanoma) cystoid macular oedema (CME). Persistent CME was defined as increased or...
Rebamipide 2% for dry eye
Rebamipide is a quinolinone derivative that has been found to increase mucin production and the number of conjunctival goblet cells. A previous phase two study has shown rebamipide 2% to be better than placebo in improving the ocular surface and...World Diabetes Day workshop highlights the importance of education to protect the sight of people living with diabetes
Health professionals from all over the world came together to mark World Diabetes Day on 14 November 2022 through an online workshop celebrating progress in development of diabetic retinopathy (DR) services in low-and middle-income countries (LMICs).College of Optometrists joins RNIB and colleagues from across the profession to launch the Eye Care Support Pathway
The College of Optometrists has joined the RNIB and senior leaders from the NHS, social care and the charity sectors, to unveil a new UK-wide Eye Care Support Pathway.Beyond 2020: An educational video series from the Amazonian rainforest
It has been estimated that one billion people globally live with visual impairment. Moreover, countries in the developing world are disproportionately affected, with four times more low vision than compared to countries with well-established systems of primary, secondary and tertiary...
